CollPlant Biotechnologies Ltd.(CLGN)

$0.31—

Chart

CollPlant Biotechnologies Ltd.(CLGN)

NASDAQ

$0.31—

Chart Studio

CLGN(CLGN)

CLGN

Overview Notebook Intelligence Chart History Fundmntls TTM Earnings Analysts News Financials Segments Insiders Institl.DCF Peers

Q3 2026 EPS Estimate

$-0.24

Aug 20, 2026 · Reports before open

Revenue Estimate

$480,000

Analyst Sentiment

Wall St. Consensus

Buy

5 analysts·Limited coverage

Score

4 Buy (80%)1 Hold (20%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

480%

Hold

120%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$11.00

+3421.1%

Consensus

$12.50

+3901.3%

Bull

$14.00

+4381.4%

12-Month Target Range5 analysts

$11.00$12.50$14.00

Current $0.31Consensus

Current Price

$0.31

Upside to Consensus

$12.19

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+25.00%

EPS—

FY2028

Rev+20.00%

EPS—

FY2029

Rev+16.67%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$2M	$3M	$3M	$4M	$4M
Low	$2M	$3M	$3M	$4M	$4M
High	$2M	$3M	$3M	$4M	$4M
EBITDA Avg	$-1M	$-2M	$-2M	$-2M	$-3M
Low	$-1M	$-2M	$-2M	$-2M	$-3M
High	$-1M	$-2M	$-2M	$-2M	$-3M
EBIT Avg	$-1M	$-2M	$-2M	$-3M	$-3M
Low	$-1M	$-2M	$-2M	$-3M	$-3M
High	$-1M	$-2M	$-2M	$-3M	$-3M
Net Income Avg	$-7M	$-2M	$-2M	$-2M	$-2M
Low	$-7M	$-2M	$-2M	$-2M	$-2M
High	$-7M	$-2M	$-2M	$-2M	$-2M
EPS Avg	$-0.59	$-0.18	$-0.17	$-0.15	$-0.14
Low	$-0.59	$-0.18	$-0.17	$-0.15	$-0.14
High	$-0.59	$-0.18	$-0.17	$-0.15	$-0.14
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027	Q1 2028	Q2 2028
Revenue Avg	$520,000	$540,000	$575,000	$600,000	$650,000	$675,000	$690,000	$720,000
Low	$520,000	$540,000	$575,000	$600,000	$650,000	$675,000	$690,000	$720,000
High	$520,000	$540,000	$575,000	$600,000	$650,000	$675,000	$690,000	$720,000
EBITDA Avg	$-361,095	$-374,983	$-399,288	$-416,648	$-451,369	$-468,729	$-479,145	$-499,978
Low	$-361,095	$-374,983	$-399,288	$-416,648	$-451,369	$-468,729	$-479,145	$-499,978
High	$-361,095	$-374,983	$-399,288	$-416,648	$-451,369	$-468,729	$-479,145	$-499,978
EBIT Avg	$-376,692	$-391,181	$-416,535	$-434,645	$-470,866	$-488,976	$-499,842	$-521,574
Low	$-376,692	$-391,181	$-416,535	$-434,645	$-470,866	$-488,976	$-499,842	$-521,574
High	$-376,692	$-391,181	$-416,535	$-434,645	$-470,866	$-488,976	$-499,842	$-521,574
Net Income Avg	$-723,102	$-690,109	$-604,877	$-622,748	$-643,369	$-609,001	$-563,635	$-581,506
Low	$-723,102	$-690,109	$-604,877	$-622,748	$-643,369	$-609,001	$-563,635	$-581,506
High	$-723,102	$-690,109	$-604,877	$-622,748	$-643,369	$-609,001	$-563,635	$-581,506
EPS Avg	$-0.05	$-0.05	$-0.04	$-0.05	$-0.05	$-0.04	$-0.04	$-0.04
Low	$-0.05	$-0.05	$-0.04	$-0.05	$-0.05	$-0.04	$-0.04	$-0.04
High	$-0.05	$-0.05	$-0.04	$-0.05	$-0.05	$-0.04	$-0.04	$-0.04
Analysts (Rev / EPS)	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1	1 / 1

Earnings Surprises

Recent Analyst Actions

Dec 2, 2024H.C. Wainwright

H.C. Wainwright Reiterates Buy Rating on Collplant Holdings Inc. (CLGN)

Target:$11.00

+153.5%from $4.34

Aug 5, 2024EF Hutton

EF Hutton Starts Collplant Holdings Inc. (CLGN) at Buy

Target:$14.00

+201.1%from $4.65

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance